Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

1993536 citationsJournal Article

Authors

A. S. Sarkis · Memorial Sloan Kettering Cancer Center

Guido Dalbagni

C. Cordon‐Cardo · Memorial Sloan Kettering Cancer Center

Victor E. Reuter · Memorial Sloan Kettering Cancer Center

Abstract

Large prospective studies are needed to confirm these results and to evaluate nuclear overexpression of p53 protein as a prognostic marker in bladder cancer.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Cancer Research and Treatments Cancer, Hypoxia, and Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 85, Issue 1, pp. 53-59

DOI: 10.1093/jnci/85.1.53

Field-Weighted Citation Impact: 46.40